| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.4M | — | +443.1% |
| Cost of Revenue | $3.3M | — | +490.2% |
| Gross Profit | $111K | — | +60.9% |
| R&D Expense | $5.7M | — | +142.7% |
| SG&A Expense | $18.7M | — | +231.3% |
| Operating Income | -$30.9M | — | -228.2% |
| Interest Expense | $1.1M | — | +834.2% |
| Pre-tax Income | -$53.1M | — | -455.6% |
| Income Tax | $0 | — | — |
| Net Income | -$53.1M | — | -455.6% |
| EPS (Basic) | -$0.09 | — | +50.0% |
| EPS (Diluted) | -$0.09 | — | +50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.2M | +10.0% | +1189.5% |
| Accounts Receivable | $1.1M | +20.0% | +280.7% |
| Inventory | $717K | +12.7% | -46.6% |
| Current Assets | $106.3M | -25.6% | +3846.1% |
| Total Assets | $250.1M | -9.0% | +161.4% |
| Current Liabilities | $23.0M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.7M | — | -44.9% |
| Capital Expenditures | $264K | — | +407.7% |
| Investing Cash Flow | -$13.9M | — | -1219.8% |
| Financing Cash Flow | $22.8M | — | +482.4% |
| Free Cash Flow | -$9.0M | — | -48.0% |
| +452.0% |
| Total Liabilities | $30.1M | -18.1% | +115.1% |
| Stockholders' Equity | $220.0M | -7.5% | +169.4% |